Prosecution Insights
Last updated: April 19, 2026
Application No. 18/624,859

Anatomical Attachment Device and Associate Methods of Use

Non-Final OA §102
Filed
Apr 02, 2024
Examiner
GRAY, PHILLIP A
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Faction Imaging Inc.
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
3y 12m
To Grant
84%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allow Rate
663 granted / 896 resolved
+4.0% vs TC avg
Moderate +10% lift
Without
With
+10.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 12m
Avg Prosecution
30 currently pending
Career history
926
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
50.3%
+10.3% vs TC avg
§102
34.4%
-5.6% vs TC avg
§112
12.2%
-27.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 896 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This office action is in response to applicant’s communication of 4/2/2024. Currently claims 1-23 are pending and rejected below. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-23 is/are rejected under 35 U.S.C. 102 (a)(2) as being anticipated by Singh et al. (US 2016/0183913 A1). Singh discloses a first transducer (40) configured to: collect first data associated with an anatomical site comprising target anatomy; and be positioned on a surface of a patient at a first location; a second transducer (42) configured to: collect second data associated with the anatomical site; and be positioned on the surface of the patient at a second location different from the first location, wherein the first transducer and the second transducer are configured to be moved independently of one another when collecting the first and second data (see para [0092]-[0094] examiner is of the position that when the device is rotated that the two would move independently via rotation of the device around an axis; or use with the glove based system disclosed or based with the OCT system in addition as a second transduccer); and one or more processors (32), the one or more processors configured to: receive the first and second data from the first and second transducers (see para [0006]; and generate (para [0079]), based on the first and second data, a three-dimensional representation of the target anatomy (see para [0194]-[0196]), wherein the target anatomy includes at least one of an organ (see para [0144]). Concerning claim 2 and the one or more processors are further configured to provide for output the three-dimensional representation of the target anatomy (see para [0144]). Concerning claim 3 and the one or more processors are further configured to receive a user input corresponding to a manipulation of the three-dimensional representation provided for output (note potential user interface 4200 and para [0106] for example). Concerning claim 4and at least one of the first transducer (40) or the second transducer (42) comprises at least one display (note output monitor 34). Concerning claim 5 and the anatomical site further comprises hard tissue, and the hard tissue is located between the target anatomy and at least one of the first transducer or the second transducer (it is examiner position that this is an intended use or functional type limitation.and this is how the device would operate as evidenced in para [0148]-[0152]). Concerning claim 6 and the at least one of the first transducer or second transducer is configured to collect the first or second data through gaps or across an outer perimeter of the hard tissue (again it is examiner position that this is an intended use or functional type limitation.and this is how the device would operate as evidenced in para [0148]-[0152]). Concerning claim 7 and further comprising at least one additional transducer configured to: collect third data associated with the anatomical site; and be positioned on the surface of the patient at a third location, the third location being different from the first and second locations (see disclosure of multiple or more than two transducers as in [0082]). Concerning claim 8 and the one or more processors are further configured to receive the third data from a third transducer; and generating the three-dimensional representation of the target anatomy is further based on the third data (note processors 32 and addition of arrayed or multiple transducers of para [0082]). Concerning claim 9 and the first transducer has a first array define a first area and the second transducer has a second array defined by a second area smaller than the first area (see para [0077] and [0152] with discuss uses with multiple arrays). Concerning claim 10 and at least one of the first transducer or the second transducer is a handheld transducer (see para [0073] and discussion of a handle or [0183 and the “hand” based glove). Concerning claim 11 and the first transducer is configured to remain stationary while collecting the first data, and the second transducer is configured to be moved while collecting the second data (see para [0092]-[0094] examiner is of the position that when the device is rotated that the two would move independently or one stationary to the other via rotation of the device around an axis; or use with the glove based system disclosed or based with the OCT system in addition as a second transducer especially when multiple transducers are used). Concerning claim 12 and the first and second data received from the first and second transducers is received in real-time (see para [0079]). Concerning claim 13 and wherein the three-dimensional representation of the target anatomy is generated in real-time (again see para [0079]). Concerning claim 14 and a method, comprising: receiving, by one or more processors (32) from a first transducer (40), first data associated with an anatomical site comprising target anatomy, the first transducer positioned on a surface of a patient at a first location; receiving, by the one or more processors from a second transducer (42), second data associated with the anatomical site, the second transducer positioned on the surface of the patient at a second location different from the first location, wherein the first transducer and the second transducer are configured to be moved independently of one another (see para [0092]-[0094] examiner is of the position that when the device is rotated that the two would move independently or one stationary to the other via rotation of the device around an axis; or use with the glove based system disclosed or based with the OCT system in addition as a second transducer especially when multiple transducers are used).when collecting the first and second data; and generate, by the one or more processors based on the first and second data, a three-dimensional representation of the target anatomy, wherein the target anatomy includes at least one of an organ (see para [0079]). Concerning claim 15 and comprising providing for output, by the one or more processors, the three-dimensional representation of the target anatomy (again see para [0079]). Concerning claim 16 and comprising receiving, by the one or more processors, a user input corresponding to a manipulation of the three-dimensional representation provided for output (note potential user interface 4200 and para [0106] for example). Concerning claim 17 and at least one of the first transducer or the second transducer comprises at least one display; and the method further comprises providing for output, by the one or more processors, the three-dimensional representation of the target anatomy on the at least one display (note output monitor 34). Concerning claim 18 and the anatomical site further comprises hard tissue, and the hard tissue is located between the target anatomy and at least one of the first transducer or the second transducer (see para [0148]-[0152]). Concerning claim 18 and comprising at least one of: collecting, by the first transducer, the first data through gaps or across an outer perimeter of the hard tissue, or collecting, by the second transducer, the second data through the gaps or across the outer perimeter of the hard tissue (again see para [0148]-[0152]). Concerning claim 20 and comprising receiving, by the one or more processors from a third transducer, third data associated with the anatomical site, the third transducer positioned on the surface of the patient at a third location different from the first and second locations (see disclosure of multiple or more than two transducers as in [0082]). Concerning claim 21 and generating the three-dimensional representation is further based on the third data (note processors 32 and addition of arrayed or multiple transducers of para [0082]). Concerning claim 22 and a system, comprising: at least one transducer (40) configured to: collect data associated with an anatomical site comprising target anatomy; and be positioned on a surface of a patient at a first location; one or more processors (32), the one or more processors configured to: receive the data from the at least one transducer; and generate, based on the real-time data, a three-dimensional representation of the target anatomy (see para [0144]), wherein the target anatomy is an organ ([0139]). Concerning claim 23 and the organ is a heart (it is examiner position that this is an intended use or functional type limitation.and this is how the device would operate as evidenced in para [0148]-[0152], it is examiner position that this device would detect a heart if in the site of a heart). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHILLIP A GRAY whose telephone number is (571)272-7180. The examiner can normally be reached M-F 9-5 EST (FLEX). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached at (571)270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. PHILLIP A. GRAY Primary Examiner Art Unit 3783 /PHILLIP A GRAY/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Apr 02, 2024
Application Filed
Jan 10, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599544
INTRAORAL GASTROINTESTINAL ACCESS DEVICE AND RELATED METHODS
2y 5m to grant Granted Apr 14, 2026
Patent 12589210
SYRINGE AND KIT FOR ADMINISTERING PREDETERMINED SPECIFIC EPINEPHRINE DOSES
2y 5m to grant Granted Mar 31, 2026
Patent 12582776
SYRINGE WITH PRIMING INDICATOR
2y 5m to grant Granted Mar 24, 2026
Patent 12582819
TREATMENT OF INFLAMMATORY DISORDERS
2y 5m to grant Granted Mar 24, 2026
Patent 12569624
Devices, Methods and Compositions for Reproductive Organs
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
84%
With Interview (+10.5%)
3y 12m
Median Time to Grant
Low
PTA Risk
Based on 896 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month